Astrea Bioseparations AB100505 Evolve 100 Column for Chromatographic Applications
Astrea Bioseparations
Details
-
CategoryBioprocessing
-
Dimension8.0in x 8.0in x 38.0in
-
Serial100-18022102
-
Shipping TypeFedEx Ground
-
Manufacturing2021-01-01
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The Astrea Bioseparations AB100505 Evolve 100 Column, manufactured in 2021, is a versatile column specifically designed for biopharmaceutical applications. Ideal for both pilot and production scale chromatographic processes, this used column is in excellent condition and fully functional. Key features include a pressure rating of 4 bar and an adjustable bed height supporting column volumes of up to 3.9 liters. It operates within a temperature range of 2 to 30 degrees Celsius and features a non-metallic flow path. Although this unit has not undergone refurbishment, it exhibits little to no cosmetic damage, making it a reliable addition to your laboratory setup. Computer and software are not included.
Key Features
- Designed for biopharmaceutical applications
- Suitable for pilot and production scale chromatographic processes
- 4 bar pressure rating
- Adjustable bed height for volumes up to 3.9L
- Operating temperature range: 2-30°C
- Non-metallic flow path
Specifications
- - Brand/Manufacturer: Astrea Bioseparations
- - Model: AB100505
- - Year of Manufacture: 2021
- - Pressure Rating: 4 bar
- - Adjustable Bed Height: Supports column volumes up to 3.9 L
- - Operating Temperature Range: 2 - 30 C
- - Non-metallic Flow Path
- - Dimensions: 226 x 1543 mm
Weight
Imperial: 54.0 Pounds
Metric: 24.49 Kilograms
Shipping Dimensions
Imperial: 9.6 lb x 9.6 lb x 45.6 lb
Metric: 24.38 cm x 24.38 cm x 115.82 cm
Harmonized Code
841989
Harmonized Code Details
Harmonized code 841989 covers machinery, plant/ laboratory equipment for treating materials by a process involving a change of temperature. This is appropriate as the column is used in chromatography which often involves temperature control.
Comments 0
There are currently no public comments.